Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market has been growing steadily in recent years, driven by increased awareness and demand for preventative healthcare measures. This trend is expected to continue in the coming years, with several key factors driving growth in different regions worldwide.
Customer preferences: Customers in the Other Vaccines market are increasingly seeking out preventative healthcare measures, particularly in the wake of recent global health crises. This has led to increased demand for vaccines that protect against a range of diseases, including those that may not be as well-known or prevalent in certain regions. Additionally, customers are increasingly willing to pay for high-quality vaccines that are proven to be effective and safe.
Trends in the market: In North America, the Other Vaccines market is being driven by a number of factors, including an aging population and the increasing prevalence of chronic diseases. This has led to increased demand for vaccines that protect against diseases like shingles and pneumonia, as well as the flu. Additionally, there is growing interest in vaccines that protect against certain types of cancer. In Europe, the Other Vaccines market is being driven by similar factors, including an aging population and the increasing prevalence of chronic diseases. However, there is also a growing focus on preventative healthcare measures, particularly in countries with strong public healthcare systems. This has led to increased demand for vaccines that protect against a range of diseases, including those that may not be as well-known or prevalent in certain regions. In Asia, the Other Vaccines market is being driven by a combination of factors, including rising incomes and increased awareness of preventative healthcare measures. This has led to increased demand for vaccines that protect against diseases like hepatitis and HPV, as well as the flu. Additionally, there is growing interest in vaccines that protect against certain types of cancer.
Local special circumstances: In some regions, there are local special circumstances that are driving growth in the Other Vaccines market. For example, in Africa, there is a growing focus on preventing infectious diseases like HIV and malaria, which has led to increased demand for vaccines that protect against these diseases. Additionally, in some countries with weaker healthcare systems, there is a growing interest in private healthcare solutions, including preventative healthcare measures like vaccines.
Underlying macroeconomic factors: Overall, the growth of the Other Vaccines market is being driven by a combination of underlying macroeconomic factors, including rising incomes, increased awareness of preventative healthcare measures, and an aging population. Additionally, recent global health crises have highlighted the importance of preventative healthcare measures, which is likely to drive continued growth in the market in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
